IL102574A - חיזור אנאנטיוספציפי של קיון אוקסאזוליל פרוכיראלי - Google Patents
חיזור אנאנטיוספציפי של קיון אוקסאזוליל פרוכיראליInfo
- Publication number
- IL102574A IL102574A IL10257492A IL10257492A IL102574A IL 102574 A IL102574 A IL 102574A IL 10257492 A IL10257492 A IL 10257492A IL 10257492 A IL10257492 A IL 10257492A IL 102574 A IL102574 A IL 102574A
- Authority
- IL
- Israel
- Prior art keywords
- process according
- borane
- methyl
- formula
- phenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US73356491A | 1991-07-22 | 1991-07-22 |
Publications (2)
Publication Number | Publication Date |
---|---|
IL102574A0 IL102574A0 (en) | 1993-01-14 |
IL102574A true IL102574A (he) | 1996-07-23 |
Family
ID=24948157
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL10257492A IL102574A (he) | 1991-07-22 | 1992-07-21 | חיזור אנאנטיוספציפי של קיון אוקסאזוליל פרוכיראלי |
Country Status (21)
Country | Link |
---|---|
US (1) | US5512689A (he) |
EP (1) | EP0595868B1 (he) |
JP (1) | JP2671962B2 (he) |
AT (1) | ATE173728T1 (he) |
AU (1) | AU660701B2 (he) |
CA (1) | CA2111445C (he) |
DE (1) | DE69227689T2 (he) |
DK (1) | DK0595868T3 (he) |
ES (1) | ES2123562T3 (he) |
FI (1) | FI940306A0 (he) |
HU (1) | HUT70412A (he) |
IE (1) | IE922359A1 (he) |
IL (1) | IL102574A (he) |
MX (1) | MX9204278A (he) |
MY (1) | MY131277A (he) |
NO (1) | NO940227D0 (he) |
NZ (1) | NZ243651A (he) |
PT (1) | PT100710B (he) |
TW (1) | TW199891B (he) |
WO (1) | WO1993002060A1 (he) |
ZA (1) | ZA925469B (he) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUT70422A (en) * | 1991-07-22 | 1995-10-30 | Pfizer | Chiral thiazole derivatives and process for preparing them |
FR2699172B1 (fr) * | 1992-12-11 | 1995-01-20 | Adir | Nouveaux dérivés de 4-méthyl-1,3-oxazole, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. |
TW416958B (en) * | 1993-05-14 | 2001-01-01 | Pfizer | Enantioselective oxazaborolidine catalysts |
ES2248107T3 (es) | 1999-08-31 | 2006-03-16 | Incyte San Diego Incorporated | Benciliden-tiazolidindionas y analogos y su utilizacion en el tratamiento de la diabetes. |
AU2002252227A1 (en) | 2001-03-07 | 2002-09-24 | Maxia Pharmaceuticals, Inc. | Heterocyclic derivatives for the treatment of cancer and other proliferative diseases |
CA2473156A1 (en) * | 2001-03-08 | 2002-09-19 | Incyte San Diego, Inc. | Rxr activating molecules |
CA2340824A1 (en) * | 2001-03-14 | 2002-09-14 | Ibm Canada Limited-Ibm Canada Limitee | Method and system for application behavior analysis |
EP1421061A4 (en) * | 2001-08-17 | 2004-12-22 | Incyte San Diego Inc | OXIME DERIVATIVES FOR THE TREATMENT OF DYSLIPIDEMIA AND HYPERCHOLESTEROLEMIA |
JP2005513026A (ja) * | 2001-11-15 | 2005-05-12 | インサイト サン ディエゴ インコーポレイテッド | 高コレステロール血症、異脂肪血症および他の代謝障害;癌、および他の疾患を治療するn−置換複素環 |
US7196108B2 (en) * | 2002-03-08 | 2007-03-27 | Incyte San Diego Inc. | Bicyclic heterocycles for the treatment of diabetes and other diseases |
US7102000B2 (en) * | 2002-03-08 | 2006-09-05 | Incyte San Diego Inc. | Heterocyclic amide derivatives for the treatment of diabetes and other diseases |
US20050014767A1 (en) * | 2003-01-29 | 2005-01-20 | Magnus Pfahl | Benzoxazole, benzothiazole, and benzimidazole derivatives for the treatment of cancer and other diseases |
MXPA05011242A (es) * | 2003-04-18 | 2006-07-06 | Incyte San Diego Inc | Compuestos isocromanos sustituidos para el tratamiento de trastornos metabolicos, cancer y otras enfermedades. |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4943635A (en) * | 1987-08-27 | 1990-07-24 | President & Fellows Of Harvard College | Enantioselective reduction of ketones |
US5036079A (en) * | 1989-12-07 | 1991-07-30 | Pfizer Inc. | Hypoglycemic thiazolidinedione derivatives |
TW222626B (he) * | 1991-07-22 | 1994-04-21 | Pfizer |
-
1992
- 1992-07-01 CA CA002111445A patent/CA2111445C/en not_active Expired - Fee Related
- 1992-07-01 DE DE69227689T patent/DE69227689T2/de not_active Expired - Fee Related
- 1992-07-01 JP JP5502810A patent/JP2671962B2/ja not_active Expired - Fee Related
- 1992-07-01 EP EP92915192A patent/EP0595868B1/en not_active Expired - Lifetime
- 1992-07-01 AU AU23062/92A patent/AU660701B2/en not_active Ceased
- 1992-07-01 ES ES92915192T patent/ES2123562T3/es not_active Expired - Lifetime
- 1992-07-01 AT AT92915192T patent/ATE173728T1/de not_active IP Right Cessation
- 1992-07-01 DK DK92915192T patent/DK0595868T3/da active
- 1992-07-01 WO PCT/US1992/005433 patent/WO1993002060A1/en active IP Right Grant
- 1992-07-01 HU HU9400188A patent/HUT70412A/hu unknown
- 1992-07-07 TW TW081105396A patent/TW199891B/zh active
- 1992-07-20 PT PT100710A patent/PT100710B/pt not_active IP Right Cessation
- 1992-07-21 IL IL10257492A patent/IL102574A/he not_active IP Right Cessation
- 1992-07-21 MX MX9204278A patent/MX9204278A/es unknown
- 1992-07-21 MY MYPI92001294A patent/MY131277A/en unknown
- 1992-07-21 IE IE235992A patent/IE922359A1/en not_active IP Right Cessation
- 1992-07-21 NZ NZ243651A patent/NZ243651A/en unknown
- 1992-07-21 ZA ZA925469A patent/ZA925469B/xx unknown
-
1994
- 1994-01-21 NO NO940227A patent/NO940227D0/no unknown
- 1994-01-21 FI FI940306A patent/FI940306A0/fi unknown
-
1995
- 1995-04-05 US US08/417,502 patent/US5512689A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
TW199891B (he) | 1993-02-11 |
WO1993002060A1 (en) | 1993-02-04 |
AU660701B2 (en) | 1995-07-06 |
IL102574A0 (en) | 1993-01-14 |
HUT70412A (en) | 1995-10-30 |
EP0595868B1 (en) | 1998-11-25 |
NO940227L (no) | 1994-01-21 |
EP0595868A1 (en) | 1994-05-11 |
HU9400188D0 (en) | 1994-05-30 |
US5512689A (en) | 1996-04-30 |
DE69227689T2 (de) | 1999-04-22 |
JP2671962B2 (ja) | 1997-11-05 |
IE922359A1 (en) | 1993-01-27 |
NZ243651A (en) | 1994-01-26 |
DK0595868T3 (da) | 1999-08-09 |
CA2111445A1 (en) | 1993-02-04 |
FI940306A (fi) | 1994-01-21 |
PT100710A (pt) | 1993-09-30 |
MY131277A (en) | 2007-07-31 |
ES2123562T3 (es) | 1999-01-16 |
JPH07502017A (ja) | 1995-03-02 |
AU2306292A (en) | 1993-02-23 |
ZA925469B (en) | 1994-01-21 |
DE69227689D1 (de) | 1999-01-07 |
MX9204278A (es) | 1994-03-31 |
FI940306A0 (fi) | 1994-01-21 |
CA2111445C (en) | 1997-02-18 |
ATE173728T1 (de) | 1998-12-15 |
PT100710B (pt) | 1999-07-30 |
NO940227D0 (no) | 1994-01-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU660701B2 (en) | Process for the preparation of intermediates in the synthesis of chiral thiazolidine-2,4-dione derivatives | |
AP776A (en) | Benzoxazoles and pyridine derivatives useful in the treatment of the type Ii diabetes. | |
CA1124245A (en) | Interphenylene-9-thia-11-oxo-12-azaprostanoic acid compounds | |
WO1995017394A1 (en) | Heterocyclic derivatives and their use in pharmaceuticals | |
CA2299447C (en) | Procedure for obtaining the enantiomers of cyzolirtine | |
JP2525127B2 (ja) | 鏡像体選択的オキサアザボロリジン | |
JP3484200B2 (ja) | チアゾリジンジオンの改良製造方法及び新規なチアゾリジンジオン | |
LU86392A1 (fr) | Intermediaires intervenant dans la production d'epipodophyllotoxine et composes apparentes:procedes de preparation et emploi | |
RU2150472C1 (ru) | Способ получения диизопинокамфеилхлорборана в реакционной смеси, способ восстановления прохирального кетона | |
JP2546559B2 (ja) | ジイソピノカンフェイルクロロボランのインシトゥー製造 | |
ARAI et al. | Stereoselective reduction of chiral 3-(p-tolylsulfinyl)-2-thienyl ketones. A facile entry to optically active thienylcarbinols | |
Yokoyama et al. | Synthetic Studies of Yessotoxin: Stereoselective Annulation of the CD and JK Ring Fragments by Using Pd (II)-Catalyzed Cyclization | |
JP2672029B2 (ja) | チアゾール系抗糖尿病薬製造用のキラル中間体 | |
US4243817A (en) | Prostenoic acids and esters | |
JPH04352745A (ja) | 光学活性アルコールの製法 | |
CA2085716A1 (en) | Heterocyclically substituted carbamates and process for their preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
RH | Patent void |